Michael A. Vogelbaum

29.0k total citations · 6 hit papers
239 papers, 12.8k citations indexed

About

Michael A. Vogelbaum is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Michael A. Vogelbaum has authored 239 papers receiving a total of 12.8k indexed citations (citations by other indexed papers that have themselves been cited), including 173 papers in Genetics, 110 papers in Pulmonary and Respiratory Medicine and 65 papers in Oncology. Recurrent topics in Michael A. Vogelbaum's work include Glioma Diagnosis and Treatment (173 papers), Brain Metastases and Treatment (103 papers) and Meningioma and schwannoma management (47 papers). Michael A. Vogelbaum is often cited by papers focused on Glioma Diagnosis and Treatment (173 papers), Brain Metastases and Treatment (103 papers) and Meningioma and schwannoma management (47 papers). Michael A. Vogelbaum collaborates with scholars based in United States, Netherlands and Germany. Michael A. Vogelbaum's co-authors include Patrick Y. Wen, Martin J. van den Bent, Susan M. Chang, David R. Macdonald, Gene H. Barnett, Marc C. Chamberlain, Wolfgang Wick, Mark R. Gilbert, David A. Reardon and Manmeet S. Ahluwalia and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Michael A. Vogelbaum

226 papers receiving 12.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

2010 2.7k citations Patrick Y. Wen, David R. Macdonald et al. Journal of Clinical Oncology profile →
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

2016 490 citations Nathalie L. Albert, Michael Weller et al. Neuro-Oncology profile →
Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline

2012 464 citations Laurie E. Gaspar, Michael A. Vogelbaum et al. profile →
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma

2014 311 citations Matthew M. Grabowski, Lilyana Angelov et al. profile →
Response Assessment in Neuro-Oncology Clinical Trials

2017 279 citations Patrick Y. Wen, Susan M. Chang et al. Journal of Clinical Oncology profile →
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma

2024 142 citations Michael A. Vogelbaum, Filippo Veglia et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Vogelbaum United States	55	8.1k	4.1k	3.2k	2.6k	2.5k	239	12.8k
Olivier Chinot France	52	7.5k 0.9×	3.3k 0.8×	1.7k 0.5×	2.2k 0.9×	1.9k 0.8×	296	11.7k
Jean‐Yves Delattre France	62	7.9k 1.0×	4.0k 1.0×	2.0k 0.6×	2.1k 0.8×	2.1k 0.8×	216	14.4k
Philip H. Gutin United States	68	7.1k 0.9×	5.0k 1.2×	3.1k 1.0×	1.8k 0.7×	3.5k 1.4×	240	14.5k
Andrew E. Sloan United States	56	6.1k 0.8×	3.5k 0.9×	2.0k 0.6×	4.1k 1.6×	1.6k 0.7×	225	14.0k
Jürgen Curschmann Switzerland	7	10.6k 1.3×	3.8k 0.9×	2.6k 0.8×	2.9k 1.1×	2.1k 0.9×	11	16.3k
Jeffrey J. Olson United States	54	5.1k 0.6×	3.6k 0.9×	1.4k 0.4×	2.4k 0.9×	2.2k 0.9×	310	11.2k
Gene H. Barnett United States	63	6.0k 0.7×	5.0k 1.2×	1.6k 0.5×	2.8k 1.1×	3.8k 1.5×	404	14.3k
Tarık Tihan United States	57	6.2k 0.8×	2.5k 0.6×	1.5k 0.5×	1.9k 0.8×	2.5k 1.0×	255	13.4k
Frederick F. Lang United States	67	8.7k 1.1×	4.3k 1.1×	2.1k 0.6×	5.1k 2.0×	2.9k 1.2×	282	18.1k
Karl Bélanger Canada	17	11.3k 1.4×	4.1k 1.0×	2.7k 0.8×	3.4k 1.3×	2.3k 0.9×	39	17.6k

Countries citing papers authored by Michael A. Vogelbaum

Since Specialization

Citations

This map shows the geographic impact of Michael A. Vogelbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Vogelbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Vogelbaum more than expected).

Fields of papers citing papers by Michael A. Vogelbaum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Vogelbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Vogelbaum. The network helps show where Michael A. Vogelbaum may publish in the future.

Co-authorship network of co-authors of Michael A. Vogelbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Vogelbaum. A scholar is included among the top collaborators of Michael A. Vogelbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Vogelbaum. Michael A. Vogelbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Padmanabhan, Jaya, Patrick T. Grogan, Derek R. Duckett, et al.. (2025). STEM-16. COMBINATION THERAPIES WITH CDK9 INHIBITORS AS A PROMISING STRATEGY TO OVERCOME THERAPY RESISTANCE IN GLIOBLASTOMAS. Neuro-Oncology. 27(Supplement_5). v81–v81.

Galldiks, Norbert, Timothy J. Kaufmann, Philipp Kickingereder, et al.. (2024). Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group. Neuro-Oncology. 26(7). 1181–1194. 21 indexed citations

Kotecha, Rupesh, Paul D. Brown, Michael A. Vogelbaum, et al.. (2024). Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: An overview. Neuro-Oncology. 27(3). 597–615. 5 indexed citations

Wen, Patrick Y., Martin J. van den Bent, Michael A. Vogelbaum, & Susan M. Chang. (2023). RANO 2.0: The revised Response Assessment in Neuro-Oncology (RANO) criteria for high- and low-grade glial tumors in adults designed for the future. Neuro-Oncology. 26(1). 2–4. 12 indexed citations

Arrillaga‐Romany, Isabel, Andrew B. Lassman, Susan L. McGovern, et al.. (2023). P11.46.A ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE (ONC201) IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA. Neuro-Oncology. 25(Supplement_2). ii84–ii84.

Ellingson, Benjamin M., Patrick Y. Wen, Susan M. Chang, et al.. (2023). Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. Neuro-Oncology. 25(6). 1017–1028. 25 indexed citations

Bayık, Defne, Cynthia F. Bartels, Dionysios C. Watson, et al.. (2022). Distinct Cell Adhesion Signature Defines Glioblastoma Myeloid-Derived Suppressor Cell Subsets. Cancer Research. 82(22). 4274–4287. 17 indexed citations

Soffietti, Riccardo, Chetan Bettegowda, Ingo K. Mellinghoff, et al.. (2022). Liquid biopsy in gliomas: A RANO review and proposals for clinical applications. Neuro-Oncology. 24(6). 855–871. 63 indexed citations

Schiff, David, Hans Messersmith, Priscilla K. Brastianos, et al.. (2022). Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline. Journal of Clinical Oncology. 40(20). 2271–2276. 47 indexed citations

10.

Otvos, Balint, Tyler Alban, Matthew M. Grabowski, et al.. (2021). Preclinical Modeling of Surgery and Steroid Therapy for Glioblastoma Reveals Changes in Immunophenotype that are Associated with Tumor Growth and Outcome. Clinical Cancer Research. 27(7). 2038–2049. 23 indexed citations

11.

Karschnia, Philipp, Émilie Le Rhun, Michael A. Vogelbaum, et al.. (2021). The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy. European Journal of Cancer. 156. 93–108. 16 indexed citations

12.

D’Amico, Randy S., Manish K. Aghi, Michael A. Vogelbaum, & Jeffrey N. Bruce. (2021). Convection-enhanced drug delivery for glioblastoma: a review. Journal of Neuro-Oncology. 151(3). 415–427. 105 indexed citations

13.

Walbert, Tobias, Rebecca A. Harrison, David Schiff, et al.. (2021). SNO and EANO practice guideline update: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neuro-Oncology. 23(11). 1835–1844. 80 indexed citations

14.

Vogelbaum, Michael A., Daria Krivosheya, Hamid Borghei‐Razavi, et al.. (2020). Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO review. Neuro-Oncology. 22(11). 1568–1579. 42 indexed citations

15.

Murphy, Erin S., Kailin Yang, John H. Suh, et al.. (2019). Prospective Phase I Dose Escalation Study for Neoadjuvant Radiosurgery for Large Brain Metastases. International Journal of Radiation Oncology*Biology*Physics. 105(1). S10–S11. 3 indexed citations

16.

Boire, Adrienne, Dieta Brandsma, Priscilla K. Brastianos, et al.. (2019). Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications. Neuro-Oncology. 21(5). 571–584. 107 indexed citations

17.

Arvold, Nils D., Terri S. Armstrong, Katherine E. Warren, et al.. (2018). Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro-Oncology. 20(7). 897–906. 37 indexed citations

18.

Juloori, Aditya, Jacob A. Miller, Manmeet S. Ahluwalia, et al.. (2017). Use of Concurrent TKIs With SRS is Associated With an Increased Rate of Radiation Necrosis Among Patients With Renal Cell Carcinoma Brain Metastasis. International Journal of Radiation Oncology*Biology*Physics. 99(2). S159–S160.

19.

Kotecha, Rupesh, John H. Suh, Gene H. Barnett, et al.. (2016). Changing Trends in Brain Metastasis: A 20-Year Review of Patient Outcomes. International Journal of Radiation Oncology*Biology*Physics. 96(2). E518–E518. 1 indexed citations

20.

Vogelbaum, Michael A., John H. Sampson, Sandeep Kunwar, et al.. (2007). CONVECTION-ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN-13-PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS. Neurosurgery. 61(5). 1031–1038. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact